Mitoxantrone and myelodysplastic syndrome Patient Reports February 12, 2012

Mitoxantrone Side Effects Report #5143520-7
Mitoxantrone side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2006. Female patient, 59 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, pneumonia . Mitoxantrone dosage: 12 MG/M2 EVERY 3 MONTHS IV DRIP. During the same period patient was treated with TYLENOL, POTASSIUM ACETATE, RESTORIL, LASIX. Patient died on 10/22/2006.

Mitoxantrone Side Effects Report #4673759-6
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Apr 21, 2005. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, myelodysplastic syndrome, pneumonia . Mitoxantrone dosage: 8 MG/M2 OTH. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, ETOPOSIDE, LEUKERAN, PREDNISONE, PREDNISOLONE, CYCLOPHOSPHAMIDE, IFOSFAMIDE. Patient died.

Mitoxantrone Side Effects Report #5031040-X
Mitoxantrone side effect was reported by a Consumer or non-health professional from AUSTRIA on Apr 21, 2005. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, myelodysplastic syndrome, pneumonia . Mitoxantrone dosage: 8 MG/M2 OTH IV. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, ETOPOSIDE, CHLORAMBUCIL, PREDNISONE, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient died.

Mitoxantrone Side Effects Report #4629859-X
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Mar 24, 2005. Female patient, 35 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, myelodysplastic syndrome. Mitoxantrone dosage: unknown. During the same period patient was treated with VENLAFAXINE, CLONAZEPAM, FOLIC ACID, DIHYDROERGOTAMINE MESYLATE, TROSPIUM CHLORIDE. Patient was hospitalized. Patient recovered.


Mitoxantrone Side Effects Report #4641763-X
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 71 years of age, was diagnosed with lymphoma  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Mitoxantrone dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, DEXAMETHASONE, RITUXIMAB, INTERFERON ALFA B. Patient died.

Mitoxantrone Side Effects Report #4641731-8
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 56 years of age, was diagnosed with lymphoma  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, refractory anaemia with an excess of blasts. Mitoxantrone dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, BLEOMYCIN, DEXAMETHASONE, ETOPOSIDE. Patient recovered.

Mitoxantrone Side Effects Report #4641920-2
Mitoxantrone side effect was reported by a Physician from on Apr 04, 2005. Female patient, 49 years of age, was diagnosed with lymphoma  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, refractory anaemia with an excess of blasts. Mitoxantrone dosage: 10 MG/M2, 1 IN 1 CYCLE, INTRAVENOUS 8 CYCLES. During the same period patient was treated with FLUDARABINE PHOSPHATE, DEXAMETHASONE, RITUXIMAB, INTERFERON ALFA. Patient died.

Mitoxantrone Side Effects Report #4641734-3
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 45 years of age, was diagnosed with lymphoma  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, refractory anaemia with an excess of blasts. Mitoxantrone dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, DEXAMETHASONE, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, BLEOMYCIN. Patient died.

Mitoxantrone Side Effects Report #4641764-1
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 42 years of age, was diagnosed with lymphoma  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, myelodysplastic syndrome, refractory anaemia with ringed sideroblasts. Mitoxantrone dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, DEXAMETHASONE, RITUXIMAB, INTERFERON ALFA. Patient died.


Mitoxantrone Side Effects Report #4641921-4
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 58 years of age, was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, myelodysplastic syndrome. Mitoxantrone dosage: 10 MG/M2, 1 IN 1 CYCLE, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, DEXAMETHASONE, RITUXIMAB, INTERFERON ALFA. Patient died.